
AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide, by preventing the next heart attack. AccuLine is developing CORA— a smart, accurate, and easy to use exam for the early detection of coronary artery disease.

AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide, by preventing the next heart attack. AccuLine is developing CORA— a smart, accurate, and easy to use exam for the early detection of coronary artery disease.
Product: CORA — 4-minute AI-powered point-of-care exam for early detection and risk stratification of coronary artery disease
Headquarters: Miami, FL, United States
Employees: 13
Total funding: USD 5,750,000 (total reported)
Recent raise: Seed round on 2024-05-01
Early detection and risk stratification of coronary artery disease (cardiac diagnostics in primary care).
Medtech / Digital Health
Most recent financing event reported as a Seed round; reporting indicates Google and Mayo Clinic among investors/partners and that multiple rounds and grants were received previously.
“eHealth Ventures; Mayo Clinic Ventures; Google; Maccabi Healthcare Services; Israel Innovation Authority; Nvidia inception program; Science Center”